Three new PhDs awarded to young researchers trained within GLYCOPHARM

GLYCOPHARM has already its first publication!

We are very proud to announce that members of GLYCOPHARM have published a review about the multifuncionality of Galectin-1 in the journal Expert Opinion on Therapeutic Targets, a monthly peer-reviewed medical journal publishing review articles and original papers on recently identified novel molecular drug targets across all therapy areas.

Specifically, the review is tittled "Context-dependent multifunctionality of galectin-1: a challenge for defining the lectin as therapeutic target" and if you are interested in this topic, you can visit our section "Publications" where you will find more information about this publication.

Congratulations to the members of GLYCOPHARM who have participated in this publication!